Iola Williams Loses Three Family Members to Glioblastoma Over Twenty Years
“Nothing has really changed,” Iola Williams said, describing her family’s decades-long encounter with the same aggressive brain cancer.
Iola Williams lost her father, mother, and younger sister to glioblastoma and similar brain tumours over a twenty-year span, according to BBC News reporting.
Billy Williams was diagnosed with glioblastoma in 2004 after collapsing while gardening, dying within weeks at age 68. Eleanor Williams developed a brain tumour a decade later in 2014, following previous treatments for breast and lung cancer, and died from treatment complications. Helen Williams received the same diagnosis in January 2024 on her 56th birthday, passing away 12 weeks later.
Brain Tumour Research states that approximately 3,200 people receive a glioblastoma diagnosis in the UK each year. Only a third of those patients survive past one year, while just 4% survive for five years or more.
The family history remains medically inexplicable as researchers find no genetic or hereditary link connecting the three cases. Hugh Adams from Brain Tumour Research said that the charity is not aware of any links based on hereditary makeup, describing the sequence as highly unusual.

“I’ve worked in this area for a long time and I’ve not heard of three members of one family, so tragically, being affected by the same tumour type,” Adams said, according to Brain Tumour Research.
Iola Williams, a 68-year-old retired psychiatric nurse from Llanfrothen in Gwynedd, said that standard clinical options have remained static across the two decades separating her family members’ diagnoses. Patients receive standard radiotherapy or chemotherapy regimens, yet medical providers still cannot identify the exact pathogenesis or origin of the tumours.
Brain Tumour Research figures show that brain tumours represent the largest cancer killer of children and adults under the age of 40 in the UK. Adams said that central government and devolved administrations have historically allocated less than 1% of national cancer research funding to the disease, though investment has begun to rise.
“Brain tumours, sadly, are the biggest cancer killer of children and adults under the age of 40, and we need to invest in research to get closer to cures,” Adams said.
Williams is urging increased financial support for research and improved patient access to clinical trials.
“We are developing a National Cancer Strategy for Wales to transform the way the health service prevents, diagnoses, and treats this set of diseases – including brain cancer,” a Welsh government spokesperson said.
Brain Tumour Research was launched as a national charity in 2009, following a 2004 initiative where several regional organisations joined forces to increase research funding. The charity functions as an umbrella organisation for various brain tumour charities throughout the UK and operates a network of dedicated Centres of Excellence.
These centres include the inaugural site at the University of Portsmouth, which hosts the largest team of laboratory-based brain tumour research experts in the country. Furthermore, the charity’s work to influence national policy is supported by the all-party parliamentary group for brain tumours, which was established in 2005 to promote research priorities to parliamentarians.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.